Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Bupivacaine

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 4 (2)

Trial Status

Completed2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07900711Not ApplicableNot Yet Recruiting

Suture Choice for Ostomy Creation

NCT01509807Phase 4CompletedPrimary

A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B504

NCT01509638Phase 4CompletedPrimary

A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501

Showing all 3 trials

Research Network

Common Treatments

  • Bupivacaine2
  • Iv Morphine Sulfate Or Sponsorapproved Equivalent1
  • Polyglactin 910 Suture1
  • Chromic Gut Suture1
  • Group 1 Standard Of Care1

Active Sponsors

  • Pacira Pharmaceuticals, Inc2
  • Registrat-Mapi2
  • University of Southern California1

Top Investigators

Related Conditions

  • Stoma Malfunction1
  • Stoma Site Incisional Hernia1
  • Stoma Complications1
  • Stoma Site Dermatitis1
  • Peristomal Wound Infection1

Activity Timeline